多模态影像环境下基于BI-RADS特征的白盒机器学习方法预测乳腺癌分子亚型
回顾性分析363例乳腺癌(Luminal A 151例、Luminal B 96例、HER2 76例、BLBC 40例),视觉描述82项BI-RADS特征,用CHAID决策树筛选特征并分类,10折交叉验证。决策树模型准确率74.1%,HER2亚型敏感度81.58%、阳性预测值95.38%,BLBC阳性预测值89.29%。
要点
- CHAID决策树从82项BI-RADS特征中筛选出7项用于分子亚型分类。
- 模型总体准确率74.1%,HER2亚型敏感度81.58%、阳性预测值95.38%。
- BLBC阳性预测值89.29%,Luminal B敏感度64.58%、阳性预测值55.86%。
核心结论
- 采用完整白盒机器学习方法,基于多模态BI-RADS特征描述可预测乳腺癌分子亚型,联合乳腺X线和MRI的BI-RADS特征可提升预测准确率且稳健。
研究设计与样本
- 回顾性评估363例乳腺癌病例(Luminal A 151例、Luminal B 96例、HER2 76例、BLBC 40例),视觉描述BI-RADS词典定义的82项特征,采用CHAID算法决策树进行特征选择和分类,10折交叉验证评估准确率、阳性预测值、敏感度和F1-score。
诊断标准与关键数值
- 决策树模型总体准确率74.1%;Luminal A敏感度79.47%、阳性预测值75.47%、F1-score 77.42%;Luminal B敏感度64.58%、阳性预测值55.86%、F1-score 59.90%;HER2敏感度81.58%、阳性预测值95.38%、F1-score 87.94%;BLBC敏感度62.50%、阳性预测值89.29%、F1-score 73.53%。
临床应用与阅片要点
- 作者认为该方法因BI-RADS的适用性和接受度而易于广泛应用,不受影像设备厂商和设置差异影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop and validate an interpretable and repeatable machine learning model approach to predict molecular subtypes of breast cancer from clinical metainformation together with mammography and MRI images.
METHODS: We retrospectively assessed 363 breast cancer cases (Luminal A 151, Luminal B 96, HER2 76, and BLBC 40). Eighty-two features defined in the BI-RADS lexicon were visually described. A decision tree model with the Chi-squared automatic interaction detector (CHAID) algorithm was applied for feature selection and classification. A 10-fold cross-validation was performed to investigate the performance (i.e., accuracy, positive predictive value, sensitivity, and F1-score) of the decision tree model.
RESULTS: Seven of the 82 variables were derived from the decision tree-based feature selection and used as features for the classification of molecular subtypes including mass margin calcification on mammography, mass margin types of kinetic curves in the delayed phase, mass internal enhancement characteristics, non-mass enhancement distribution on MRI, and breastfeeding history. The decision tree model accuracy was 74.1%. For each molecular subtype group, Luminal A achieved a sensitivity, positive predictive value, and F1-score of 79.47%, 75.47%, and 77.42%, respectively; Luminal B showed a sensitivity, positive predictive value, and F1-score of 64.58%, 55.86%, and 59.90%, respectively; HER2 had a sensitivity, positive predictive value, and F1-scores of 81.58%, 95.38%, and 87.94%, respectively; BLBC showed sensitivity, positive predictive value, and F1-scores of 62.50%, 89.29%, and 73.53%, respectively.
CONCLUSIONS: We applied a complete "white box" machine learning method to predict the molecular subtype of breast cancer based on the BI-RADS feature description in a multi-modal setting. By combining BI-RADS features in both mammography and MRI, the prediction accuracy is boosted and robust. The proposed method can be easily applied widely regardless of variability of imaging vendors and settings because of the applicability and acceptance of the BI-RADS.
引用
- Wu M, Zhong X, Peng Q, et al. Prediction of molecular subtypes of breast cancer using BI-RADS features based on a "white box" machine learning approach in a multi-modal imaging setting. Eur J Radiol. 2019. PMID: 31005170. doi:10.1016/j.ejrad.2019.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。